Cost-analysis of four diagnostic strategies for Pneumocystis carinii pneumonia in HIV-infected subjects

The aim of this study was to analyse the cost-effectiveness ratio of four diagnostic strategies for Pneumocystis carinii pneumonia (PCP) in patients infected with human immunodeficiency virus (HIV). Two hundred and ten HIV-infected patients with suspected PCP underwent induced-sputum (IS) followed,...

Full description

Saved in:
Bibliographic Details
Published inThe European respiratory journal Vol. 8; no. 9; pp. 1554 - 1558
Main Authors Chouaid, C, Housset, B, Lebeau, B
Format Journal Article
LanguageEnglish
Published Leeds Eur Respiratory Soc 01.09.1995
Maney
European Respiratory Society
Subjects
Online AccessGet full text
ISSN0903-1936
1399-3003
1399-3003
DOI10.1183/09031936.95.08091554

Cover

Abstract The aim of this study was to analyse the cost-effectiveness ratio of four diagnostic strategies for Pneumocystis carinii pneumonia (PCP) in patients infected with human immunodeficiency virus (HIV). Two hundred and ten HIV-infected patients with suspected PCP underwent induced-sputum (IS) followed, if negative, by bronchoalveolar lavage (BAL); 85 of these patients were able to undergo an exercise test (ET), prior to induced sputum and BAL. The following strategies were analysed: BAL strategy (BAL whenever PCP is suspected); IS strategy (induced sputum followed by BAL if negative); exercise test (ET) strategy, (ET followed by BAL if the results are abnormal); and the ES (exercise sputum) strategy (i.e. BAL only after abnormal ET and negative IS). The cost of each strategy was calculated by taking into account only direct costs; the conditions in which two given strategies would be cost-equivalent were also evaluated. The prevalence of PCP in this population was 31%; IS had 100% specificity and 71% sensitivity, whilst ET had 100% sensitivity and 77% specificity. The costs of BAL, IS, ET and ES strategies were 210,000, 191,940, 140,700 and 112,700 FF, respectively. The ES strategy is, thus, most suitable for our unit. The most economic strategy depends not only on the cost and characteristics of the procedures, but also on the prevalence of PCP in the test population. In conclusion, we developed a model for use by diagnostic centres in choosing the most suitable strategy, on the basis of the local prevalence of PCP.
AbstractList The aim of this study was to analyse the cost-effectiveness ratio of four diagnostic strategies for Pneumocystis carinii pneumonia (PCP) in patients infected with human immunodeficiency virus (HIV). Two hundred and ten HIV-infected patients with suspected PCP underwent induced-sputum (IS) followed, if negative, by bronchoalveolar lavage (BAL); 85 of these patients were able to undergo an exercise test (ET), prior to induced sputum and BAL. The following strategies were analysed: BAL strategy (BAL whenever PCP is suspected); IS strategy (induced sputum followed by BAL if negative); exercise test (ET) strategy, (ET followed by BAL if the results are abnormal); and the ES (exercise sputum) strategy (i.e. BAL only after abnormal ET and negative IS). The cost of each strategy was calculated by taking into account only direct costs; the conditions in which two given strategies would be cost-equivalent were also evaluated. The prevalence of PCP in this population was 31%; IS had 100% specificity and 71% sensitivity, whilst ET had 100% sensitivity and 77% specificity. The costs of BAL, IS, ET and ES strategies were 210,000, 191,940, 140,700 and 112,700 FF, respectively. The ES strategy is, thus, most suitable for our unit. The most economic strategy depends not only on the cost and characteristics of the procedures, but also on the prevalence of PCP in the test population. In conclusion, we developed a model for use by diagnostic centres in choosing the most suitable strategy, on the basis of the local prevalence of PCP.
The aim of this study was to analyse the cost-effectiveness ratio of four diagnostic strategies for Pneumocystis carinii pneumonia (PCP) in patients infected with human immunodeficiency virus (HIV). Two hundred and ten HIV-infected patients with suspected PCP underwent induced-sputum (IS) followed, if negative, by bronchoalveolar lavage (BAL); 85 of these patients were able to undergo an exercise test (ET), prior to induced sputum and BAL. The following strategies were analysed: BAL strategy (BAL whenever PCP is suspected); IS strategy (induced sputum followed by BAL if negative); exercise test (ET) strategy, (ET followed by BAL if the results are abnormal); and the ES (exercise sputum) strategy (i.e. BAL only after abnormal ET and negative IS). The cost of each strategy was calculated by taking into account only direct costs; the conditions in which two given strategies would be cost-equivalent were also evaluated. The prevalence of PCP in this population was 31%; IS had 100% specificity and 71% sensitivity, whilst ET had 100% sensitivity and 77% specificity. The costs of BAL, IS, ET and ES strategies were 210,000, 191,940, 140,700 and 112,700 FF, respectively. The ES strategy is, thus, most suitable for our unit. The most economic strategy depends not only on the cost and characteristics of the procedures, but also on the prevalence of PCP in the test population. In conclusion, we developed a model for use by diagnostic centres in choosing the most suitable strategy, on the basis of the local prevalence of PCP.The aim of this study was to analyse the cost-effectiveness ratio of four diagnostic strategies for Pneumocystis carinii pneumonia (PCP) in patients infected with human immunodeficiency virus (HIV). Two hundred and ten HIV-infected patients with suspected PCP underwent induced-sputum (IS) followed, if negative, by bronchoalveolar lavage (BAL); 85 of these patients were able to undergo an exercise test (ET), prior to induced sputum and BAL. The following strategies were analysed: BAL strategy (BAL whenever PCP is suspected); IS strategy (induced sputum followed by BAL if negative); exercise test (ET) strategy, (ET followed by BAL if the results are abnormal); and the ES (exercise sputum) strategy (i.e. BAL only after abnormal ET and negative IS). The cost of each strategy was calculated by taking into account only direct costs; the conditions in which two given strategies would be cost-equivalent were also evaluated. The prevalence of PCP in this population was 31%; IS had 100% specificity and 71% sensitivity, whilst ET had 100% sensitivity and 77% specificity. The costs of BAL, IS, ET and ES strategies were 210,000, 191,940, 140,700 and 112,700 FF, respectively. The ES strategy is, thus, most suitable for our unit. The most economic strategy depends not only on the cost and characteristics of the procedures, but also on the prevalence of PCP in the test population. In conclusion, we developed a model for use by diagnostic centres in choosing the most suitable strategy, on the basis of the local prevalence of PCP.
Author Housset, B
Lebeau, B
Chouaid, C
Author_xml – sequence: 1
  fullname: Chouaid, C
– sequence: 2
  fullname: Housset, B
– sequence: 3
  fullname: Lebeau, B
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2891437$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/8575584$$D View this record in MEDLINE/PubMed
https://hal.sorbonne-universite.fr/hal-00597491$$DView record in HAL
BookMark eNqNkUFvFCEYhompqdvqP9CEgzbxMCsMMIC3ZlPdJpvoQb0Slvlmy2YWVpix2X8v253WxIueILzP-yXfwwU6CzEAQq8pmVOq2AeiCaOaNXMt5kQRTYXgz9CMMq0rRgg7Q7MjUh2ZF-gi5y0htOGMnqNzJaQQis_QZhHzUNlg-0P2GccOd3FMuPV2E0riHc5DsgNsPOQSJfw1wLiL7lCyjJ1NPniP9w-PwVvsA17e_qh86MAN0OI8rrflll-i553tM7yazkv0_dPNt8WyWn35fLu4XlWOiYZXquXEaV03tlPQ0RZaxqBeSyJBtoI3DbWsbUAx57pa1E4pkDVXdd0AaFEDu0TiNHcMe3u4t31v9snvbDoYSszRm3n0ZrQwj95K7_2pd2f_NKL1Znm9Msc3QoSWXNNftLBXJ3af4s8R8mB2PjvoexsgjtlIKRWRShTwzQSO6x20T3Mn-yV_O-U2O9t3yQbn8xNWK005kwXjJ8ylmHOC7n9X-vhXzfnBDj6G8qO-_1f53eTDb-7ufQKTd0VmWYQaSFtltHngfgMJnsIP
CitedBy_id crossref_primary_10_1586_eri_10_42
crossref_primary_10_1086_368214
crossref_primary_10_1016_j_cmi_2021_08_017
crossref_primary_10_1183_09031936_02_01372002
crossref_primary_10_3390_jof8030222
crossref_primary_10_1128_cmr_00101_22
ContentType Journal Article
Copyright 1996 INIST-CNRS
Distributed under a Creative Commons Attribution 4.0 International License
Copyright_xml – notice: 1996 INIST-CNRS
– notice: Distributed under a Creative Commons Attribution 4.0 International License
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
1XC
ADTOC
UNPAY
DOI 10.1183/09031936.95.08091554
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
Hyper Article en Ligne (HAL)
Unpaywall for CDI: Periodical Content
Unpaywall
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE

MEDLINE - Academic
CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: UNPAY
  name: Unpaywall
  url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1399-3003
EndPage 1558
ExternalDocumentID 10.1183/09031936.95.08091554
oai:HAL:hal-00597491v1
8575584
2891437
10_1183_09031936_95_08091554
erj8_9_1554
Genre Journal Article
GeographicLocations France
GeographicLocations_xml – name: France
GroupedDBID -
02
2WC
3O-
53G
55
5GY
5RE
5VS
AALRV
AAPBV
ABFLS
ABOCM
ABSGY
ABYBQ
ACPRK
ADACO
ADBBV
ADDZX
AENEX
AFFNX
AJYGW
ALMA_UNASSIGNED_HOLDINGS
BAWUL
CAG
CS3
DIK
E3Z
EBS
EJD
F5P
FH7
GJ
GX1
H13
INIJC
KQ8
L7B
O0-
OK1
P2P
PQEST
PQQKQ
R0Z
RHF
RHI
TER
WOQ
X7M
ZA5
ZE2
ZGI
ZXP
---
.55
.GJ
18M
AAFWJ
AAYXX
AAZMJ
ABCQX
ABJNI
ABSQV
ACEMG
ACGFO
ADMOG
ADYFA
AFHIN
AIZTS
BTFSW
CITATION
F9R
TR2
W8F
~02
1OC
31~
8-1
AADJU
ACXQS
AFZJQ
AJAOE
COF
IQODW
J5H
LH4
LW6
CGR
CUY
CVF
ECM
EIF
NPM
7X8
1XC
ADTOC
UNPAY
ID FETCH-LOGICAL-c3564-8d40c9926af8ef1ded33e2b707e7d54661a3d6e83ccf252c88e7248226ee952e3
IEDL.DBID UNPAY
ISSN 0903-1936
1399-3003
IngestDate Tue Aug 19 22:48:48 EDT 2025
Tue Oct 14 20:26:56 EDT 2025
Thu Sep 04 19:19:31 EDT 2025
Wed Feb 19 01:11:56 EST 2025
Wed Apr 02 07:26:10 EDT 2025
Thu Apr 24 23:08:33 EDT 2025
Wed Oct 01 06:53:09 EDT 2025
Tue Nov 10 20:54:46 EST 2020
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 9
Keywords Human
Immunopathology
Protozoa
Costs
Pneumonia
Respiratory disease
Lung
Pneumocystis carinii
AIDS
Parasitosis
Immune deficiency
Infection
Viral disease
Complication
Diagnosis
Technique
Sporozoa
Comparative study
Language English
License CC BY 4.0
Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3564-8d40c9926af8ef1ded33e2b707e7d54661a3d6e83ccf252c88e7248226ee952e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://proxy.k.utb.cz/login?url=https://erj.ersjournals.com/content/erj/8/9/1554.full.pdf
PMID 8575584
PQID 77780785
PQPubID 23479
PageCount 5
ParticipantIDs unpaywall_primary_10_1183_09031936_95_08091554
hal_primary_oai_HAL_hal_00597491v1
proquest_miscellaneous_77780785
pubmed_primary_8575584
pascalfrancis_primary_2891437
crossref_primary_10_1183_09031936_95_08091554
crossref_citationtrail_10_1183_09031936_95_08091554
highwire_smallpub1_erj8_9_1554
ProviderPackageCode RHF
RHI
CITATION
AAYXX
PublicationCentury 1900
PublicationDate 1995-Sep
PublicationDateYYYYMMDD 1995-09-01
PublicationDate_xml – month: 09
  year: 1995
  text: 1995-Sep
PublicationDecade 1990
PublicationPlace Leeds
PublicationPlace_xml – name: Leeds
– name: England
PublicationTitle The European respiratory journal
PublicationTitleAlternate Eur Respir J
PublicationYear 1995
Publisher Eur Respiratory Soc
Maney
European Respiratory Society
Publisher_xml – name: Eur Respiratory Soc
– name: Maney
– name: European Respiratory Society
SSID ssj0016431
Score 1.5360258
Snippet The aim of this study was to analyse the cost-effectiveness ratio of four diagnostic strategies for Pneumocystis carinii pneumonia (PCP) in patients infected...
SourceID unpaywall
hal
proquest
pubmed
pascalfrancis
crossref
highwire
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1554
SubjectTerms AIDS-Related Opportunistic Infections
AIDS-Related Opportunistic Infections - diagnosis
Biological and medical sciences
Bronchoalveolar Lavage
Bronchoalveolar Lavage - economics
Bronchoalveolar Lavage - methods
Clinical Laboratory Techniques - economics
Costs and Cost Analysis
Exercise Test
Exercise Test - economics
Exercise Test - methods
France
Humans
Immunodeficiencies
Immunodeficiencies. Immunoglobulinopathies
Immunopathology
Laboratory Techniques and Procedures
Life Sciences
Medical sciences
Pneumonia, Pneumocystis
Pneumonia, Pneumocystis - diagnosis
Prevalence
Respiratory Function Tests
Respiratory Function Tests - economics
Santé publique et épidémiologie
Sensitivity and Specificity
Sputum
Sputum - microbiology
Title Cost-analysis of four diagnostic strategies for Pneumocystis carinii pneumonia in HIV-infected subjects
URI http://erj.ersjournals.com/cgi/content/abstract/8/9/1554
https://www.ncbi.nlm.nih.gov/pubmed/8575584
https://www.proquest.com/docview/77780785
https://hal.sorbonne-universite.fr/hal-00597491
https://erj.ersjournals.com/content/erj/8/9/1554.full.pdf
UnpaywallVersion publishedVersion
Volume 8
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 1399-3003
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0016431
  issn: 0903-1936
  databaseCode: KQ8
  dateStart: 19880101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVBFR
  databaseName: Free Medical Journals at publisher websites
  customDbUrl:
  eissn: 1399-3003
  dateEnd: 20240505
  omitProxy: true
  ssIdentifier: ssj0016431
  issn: 0903-1936
  databaseCode: DIK
  dateStart: 19940101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVFQY
  databaseName: GFMER Free Medical Journals
  customDbUrl:
  eissn: 1399-3003
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0016431
  issn: 0903-1936
  databaseCode: GX1
  dateStart: 0
  isFulltext: true
  titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php
  providerName: Geneva Foundation for Medical Education and Research
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLZYJ3F54LqJACsW4jVpGie-PFYTU7lsGhJFgxfLiW0odGnVNKDx6zmnuWhDSFxefXwi2f4cf7aPv0PI89gznyF4jZMKNigmDpUVSZhLabkELybxofDxCZ_O0ldn2dmlVF9u_SUC3tN2ZPOvxqBt-AOjbSRHaoRLYISn09HK-h2yyzOg4QOyOzs5nXzYauthvJXapgcEgoN3-zFrn80BgkdoR3OksggIEyqkp1eWpZ3PGBTZCwZjvKSpoMt8k-vid2T0FrlRlytz8d0sFpcWqKM75GPXtCYu5WtUb_Ko-PGL6uN_tf0uud3SVjppcHaPXHPlfXL9uL2Yf0A-HS6rTWhahRO69NSDC7VNIB840WrTiVKAaU1PS1efL4sLsFW0MHiPNKerbWE5N3Re0unL92ETKuYsreocD4yqPTI7evHucBq2ORzCgmU8DaVN40KphBsvnR9bZxlzSS5i4YTNUmAHhlnuJCsKn2RJIaUTSQqshTunssSxfTIol6V7SGg8drFjBiX0eOpSaZgR3HMbW5da7vOAsG4IddEKnGOejYXebnQk093Aa5XpbuADEvZeq0bg4w_1nwE6-qqozj2dvNFYhg95RarG38YBGXbg0dU5QAJAMtYwhlIr3Xzl4Aqk-u_B_hcYrAjI0w5iGuY7XuKY0i3rSgshMEVAFpD9Bnm9K-ZaBToZkKhH4l-16NG_OjwmN5uH_Rhp94QMNuvaHQA12-RDsvP6rRy2U_EnjJgx6g
linkProvider Unpaywall
linkToUnpaywall http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELboVuJx4F0RoMVCXJNN4sSP46qiWhCtemBR4WI5sV0WttnVZgMqv56ZzUMtQuJx9Xgi2f4cf7bH3xDyKvbM5whe46SCDYqJQ2VFGhZSWi7Bi0l8KHx8wqez7O1ZfnYl1Zdbf4mA93Qd2f6rMWgb_sBoG8uxGuMSGOHpdLSyfofs8hxo-Ijszk5OJx-32noYb6W26QGB4ODdfsy6Z3OA4DHa0RypPALChArp2bVlaeczBkUOgsEYL2lq6DLf5rr4HRm9Q2411cpcfjeLxZUF6uge-dQ3rY1L-Ro1myIqf_yi-vhfbb9P7na0lU5anD0gN1z1kNw87i7mH5Hzw2W9CU2ncEKXnnpwobYN5AMnWm96UQowrelp5ZqLZXkJtpqWBu-R5nS1Lazmhs4rOn3zIWxDxZyldVPggVH9mMyOXr8_nIZdDoewZDnPQmmzuFQq5cZL5xPrLGMuLUQsnLB5BuzAMMudZGXp0zwtpXQizYC1cOdUnjq2R0bVsnJPCI0TFztmUEKPZy6ThhnBPbexdZnlvggI64dQl53AOebZWOjtRkcy3Q-8VrnuBz4g4eC1agU-_lD_JaBjqIrq3NPJO41l-JBXZCr5lgTkoAePri8AEgCSRMMYSq10-5X9a5Aavgf7X2CwIiAveohpmO94iWMqt2xqLYTAFAF5QPZa5A2umGsV6GRAogGJf9Wip__q8Izcbh_2Y6TdczLarBu3D9RsUxx0k_AnZsgw9Q
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Cost-analysis+of+four+diagnostic+strategies+for+Pneumocystis+carinii+pneumonia+in+HIV-infected+subjects&rft.jtitle=The+European+respiratory+journal&rft.au=Chouaid%2C+C&rft.au=Housset%2C+B&rft.au=Lebeau%2C+B&rft.date=1995-09-01&rft.issn=0903-1936&rft.volume=8&rft.issue=9&rft.spage=1554&rft_id=info:doi/10.1183%2F09031936.95.08091554&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0903-1936&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0903-1936&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0903-1936&client=summon